What are the Human Papillomavirus (HPV) vaccination guidelines for an 11-year-old female and a 17-year-old male?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

HPV Vaccination Guidelines for 11-Year-Old Female and 17-Year-Old Male

Both the 11-year-old female and 17-year-old male should receive the HPV vaccine, with the 11-year-old female requiring a 2-dose schedule and the 17-year-old male requiring a 3-dose schedule to optimize protection against HPV-related cancers and diseases. 1

Recommendations for 11-Year-Old Female

Vaccination Schedule

  • The 11-year-old female should receive the HPV vaccine as part of routine vaccination at this age 2
  • She qualifies for the 2-dose schedule since she is under 15 years of age 3
  • The doses should be administered at 0 and 6-12 months apart 1
  • The 6-month interval between doses is preferable as it produces a more robust immune response than shorter intervals 2

Vaccine Type

  • The 9-valent HPV vaccine (9vHPV, Gardasil-9) should be administered as it is currently the only available HPV vaccine in the United States 2
  • This vaccine provides protection against HPV types 6,11,16,18,31,33,45,52, and 58 2

Administration

  • The vaccine should be administered intramuscularly, preferably in the deltoid muscle 1
  • It can be administered during the same visit as other age-appropriate vaccines 2
  • Consider having the patient sit or lie down for 15 minutes after administration due to potential for syncope (fainting) in adolescents 2

Recommendations for 17-Year-Old Male

Vaccination Schedule

  • The 17-year-old male should receive the HPV vaccine as catch-up vaccination 2
  • He requires a 3-dose schedule (0,2,6 months) since he is over 15 years of age 3
  • Vaccination is recommended for males through age 21 years who have not been vaccinated previously or who have not completed the series 2

Vaccine Type

  • The 9-valent HPV vaccine (9vHPV, Gardasil-9) should be administered 2
  • This vaccine has been shown to be effective in males, with studies demonstrating adequate immune responses 4

Administration

  • The vaccine should be administered intramuscularly, preferably in the deltoid muscle 1
  • It can be administered during the same visit as other age-appropriate vaccines 2
  • Consider having the patient sit or lie down for 15 minutes after administration due to potential for syncope (fainting) in adolescents 2

Important Considerations

Efficacy and Timing

  • HPV vaccination is most effective when administered before potential exposure to HPV through sexual contact 2
  • Antibody responses are highest in younger age groups (9-15 years) 2
  • For the 17-year-old male, while vaccination at older ages may be less effective in lowering cancer risk, it still provides significant protection 2

Contraindications and Precautions

  • The vaccine should not be given to individuals with a history of immediate hypersensitivity to yeast or any vaccine component 2
  • Vaccination should be deferred for individuals with moderate or severe acute illness 2
  • Pregnancy testing is not required before starting HPV vaccination, but the vaccine is not recommended during pregnancy 1

Follow-up

  • Schedule follow-up appointments for subsequent doses at the time of initial vaccination 1
  • If doses are administered at shorter-than-recommended intervals, they should be readministered 1
  • If the vaccination schedule is interrupted, it does not need to be restarted - simply continue where left off 1

Rationale for Vaccination

  • HPV is the most common sexually transmitted infection in the United States, with approximately 14 million new infections occurring annually 2
  • The lifetime risk of acquiring an HPV infection is >80% 2
  • High-risk HPV types are responsible for virtually all cases of cervical cancer and a large percentage of anogenital and oropharyngeal cancers in both females and males 2
  • More than 26,000 new cases of HPV-related cancers are diagnosed annually in the United States 2
  • Vaccination at ages 9-12 years has shown stronger immune responses compared to vaccination at older ages 2, 5

By following these guidelines, both the 11-year-old female and 17-year-old male will receive appropriate protection against HPV-related diseases, with optimal timing for the female and still significant benefit for the male despite his older age.

References

Guideline

Immunization Guidelines for Adolescents

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.